[CITATION][C] Central nervous system graft‐versus‐host disease post allogeneic stem cell transplant
Levine, RL, Wadleigh, M., Cools, J., Ebert, BL, Wernig, G., Huntly, BJ, Boggon, TJ,
Wlodarska, I., Clark, JJ, Moore, S., Adelsperger, J., Koo, S., Lee, JC, Gabriel, S., Mercher, T.,
D'Andrea, A., Frohling, S., Dohner, K., Marynen, P., Vandenberghe, P., Mesa, RA, Tefferi, A.,
Griffin, JD, Eck, MJ, Sellers, WR, Meyerson, M., Golub, TR, Lee, SJ & Gilliland, DG (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential
thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387–397.
Wlodarska, I., Clark, JJ, Moore, S., Adelsperger, J., Koo, S., Lee, JC, Gabriel, S., Mercher, T.,
D'Andrea, A., Frohling, S., Dohner, K., Marynen, P., Vandenberghe, P., Mesa, RA, Tefferi, A.,
Griffin, JD, Eck, MJ, Sellers, WR, Meyerson, M., Golub, TR, Lee, SJ & Gilliland, DG (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential
thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387–397.
Levine, RL, Wadleigh, M., Cools, J., Ebert, BL, Wernig, G., Huntly, BJ, Boggon, TJ, Wlodarska, I., Clark, JJ, Moore, S., Adelsperger, J., Koo, S., Lee, JC, Gabriel, S., Mercher, T., D’Andrea, A., Frohling, S., Dohner, K., Marynen, P., Vandenberghe, P., Mesa, RA, Tefferi, A., Griffin, JD, Eck, MJ, Sellers, WR, Meyerson, M., Golub, TR, Lee, SJ & Gilliland, DG (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387–397.
Wiley Online Library